A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer Treated With Pyrrolidine Maleate and Capecitabine Combined With Brain Radiotherapy
Latest Information Update: 09 Jul 2023
At a glance
- Drugs Capecitabine (Primary) ; Pyrotinib (Primary)
- Indications Brain metastases; HER2 positive breast cancer
- Focus Therapeutic Use
Most Recent Events
- 09 Jul 2023 Planned number of patients changed from 43 to NULL.
- 09 Jul 2023 New trial record
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology.